How Recombinant LAL Reagents Differ From Each Other

July 29, 2026

Commercially available recombinant reagents for the Bacterial Endotoxin Test (BET) now come in two types: recombinant Factor C (rFC) and recombinant Cascade Reagent (rCR).  Additionally, progress has been made by each pharmacopeia to add these reagents as compendial BET methods, but these efforts are not currently harmonized, so considering the validation of each individual method as an alternative is the best practice for global acceptance.

Pharmaceutical products, including vaccines, can be contaminated by endotoxins, which are heat-stable lipopolysaccharides from gram-negative bacteria. The pyrogenic properties of endotoxins necessitate endotoxin testing for parenteral pharmaceutical products to prevent severe physiological reactions in patients. Currently, the prevalent method for testing is the animal-derived LAL assay. However, assays using recombinant factors, reagents not derived from animals, have been suggested as alternatives and proposed as methods for compendial acceptance.^{1, 2}

Recombinant Factor C (rFC) 

The Ph. Eur. recognizes rFC assays as an official method, and the USP recognizes rFCs as a compendial alternative.³ rFC reagents consist solely of the recombinant Factor C component of the coagulation cascade. This testing uses an endpoint fluorometric method.² The methods described in Ph.Eur 2.6.32 and USP <86> for rFC is the description for this endpoint fluorescent method. 

Recombinant Cascade Reagent (rCR) 

The Ph. Eur. has mentioned rCR as an alternative method, and the USP recognizes rCR as a compendial alternative. The cascade reaction of three protease enzymes and a coagulogen factor is the foundation of the molecular mechanism for LAL reagents. The cascade begins with the activation of the zymogen (Factor C) by the endotoxin. Factor C's activation triggers the activation of Factor B, which, in addition to its known role in the coagulation cascade (transmitting signals from Factor C), also binds to endotoxin. The stepwise activation amplifies signals, enhancing sensitivity. The protease activity of the rCR, containing rFC, is significantly higher than that of recombinant Factor C alone, demonstrating the substantial signal amplification achieved through the cascade reaction.

The proclotting enzyme is the third enzyme added. A chromophore is added that is activated by the clotting enzyme, just as it is a part of chromogenic LAL reagent. The rCR testing methodology parallels the photometric quantitative (kinetic chromogenic) techniques outlined in USP <85>. The ability to run kinetic measurements allows for lower sensitivities to be measured, equivalent to the Kinetic Chromogenic Assay (KCA) reagents in USP <85>. Kinetic measurements typically allow for a finer sensitivity and wider quantification range as they can accommodate the multiple different activation times of many standard concentrations.  

PYROSTAR Neo +: A Superior rCR Based Alternative

Recombinant proteins offer a sustainable, animal-free method for mass production, eliminating ethical concerns and scaling limitations.⁴

The PYROSTAR Neo+ line of endotoxin detection reagents developed with recombinant proteins, uses the KCA to detect gram-negative bacterial endotoxin levels. These reagents are a comprehensive solution for LAL assays, incorporating recombinant Factor C and Factor B, the proclotting enzyme (essential LAL components), a chromogenic substrate, and a suitable buffer solution. A chromogenic substrate allows for the quantitative measurement of endotoxin levels, mirroring the process of the traditional LAL method and providing a precise numerical result.

Furthermore, the PYROSTAR Neo+ system demonstrates a decrease in interference from certain medications and exhibits heightened sensitivity to naturally occurring endotoxins, thus broadening its applicability to a wider array of samples and uses, such as evaluating product safety and analyzing pharmaceutical materials and the water used in their production. 

Learn more about PYROSTAR Neo+ and other pyrogen and sterility testing solutions.

---

References:

1. Marius, M., Vacher, F. & Bonnevay, T. (2020). Comparison of LAL and recombinant Factor C endotoxin testing assays in human vaccines with complex matrices. PDA Journal of Pharmaceutical Science and Technology, 74: pdajpst.2019.010389.
2. Bacterial Endotoxins Test Using Recombinant Reagents. United States Pharmacopeia. USP <86>. 2025; USP-NF. Rockville, MD. 
3. Kang, D.H., Yun, S.Y., Eum, S., Yoon, K.E., Ryu, S.R., Lee, C., et al. (2024). A Study on the Application of Recombinant Factor C (rFC) Assay Using Biopharmaceuticals. Microorganisms, 12(3): 516.
4. What is the status of recombinant cascade reagents (rCR) in the Ph. Eur.? Faq.edqm.eu. Accessed July 2026;